PRE -FEASIBILITY REPORT Introduction of the...
Transcript of PRE -FEASIBILITY REPORT Introduction of the...
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
1
PRE-FEASIBILITY REPORT
1. Introduction of the project
M/s Sunlight Active Drug Ingredients Pvt.Ltd is promoted by Sri T.Venkateshwara Rao
and Ms T.Nitya. Industry proposes to establish a bulk drugs, Intermediates and
chemicals manufacturing industry The unit is located on plot Nos.
268,269,270,271,KIADB’s Industrial Area, Kadechur Village, Yadgir Dist, Karnataka.
State. The extent of the industrial plot is 32376 square meters
2. Need of the project
The Indian pharmaceuticals market witnessed growth at a CAGR of 5.64 per cent, during FY11-16, with the market increasing from US$ 20.95 billion in FY11 to US$ 27.57 billion in FY16. The industry’s revenues are estimated to have grown by 7.4 per cent in FY17.
Indian pharmaceutical market grew 5.5 per cent in CY2017 in terms of moving annual turnover. In March 2018, the market grew at 9.5 per cent year-on-year with sales of Rs 10,029 crore (US$ 1.56 billion).
By 2020, India is likely to be among the top three pharmaceutical markets by
incremental growth and 6th largest market globally in absolute size.
Indian pharmaceutical sector industry supplies over 50 per cent of global demand for
various vaccines, 40 per cent of generic demand in the US and 25 per cent of all
medicine in UK. India contributes the second largest share of pharmaceutical and
biotech workforce in the world. In March 2018, the Indian pharmaceutical market grew
at 9.5 per cent year-on-year.
With 71 per cent market share, generic drugs form the largest segment of the Indian
pharmaceutical sector. India has become the third largest global generic API merchant
market by 2016, with a 7.2 per cent market share. The country accounts for the second
largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s
leader in Drug Master Files (DMFs) applications with the US Indian Drugs &
Pharmaceuticals sector has received cumulative FDI worth US$ 15.59 billion between
April 2000 and December 2017.
Indian drugs are exported to more than 200 countries in the world, with the US as the
key market. Generic drugs account for 20 per cent of global exports in terms of volume,
making the country the largest provider of generic medicines globally and expected to
expand even further in coming years. India’s pharmaceutical exports stood at US$ 17.27
billion in 2017-18.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
2
At a growth rate of 9 percent per year, the pharmaceutical industry in India is well set
for rapid expansion. As a result of the expansion, the Indian pharmaceutical and
healthcare market is undergoing a spurt of growth in its coverage, services, and
spending in the public and private sectors.
Increase in the size of middle class households coupled with the improvement in medical infrastructure and increase in the penetration of health insurance in the country will also influence in the growth of pharmaceuticals sector. Based on the above study .many more pharmaceutical manufacturing industries are required. Source: Indian Pharmaceuticals Industry Analysis
3. Project Description
3.1 Project details
Sl.No Description Details
I Name of the project M/s Sunlight Active Drug Ingredients Pvt.Ltd
II Location
Village Kadechur
Area KIADB Industrial area
District Yadgir
State Karnataka
III Land use pattern
Total Land area in SQM 32376
Built-up area 17159
Production Block 11764
Storage yard 827
Roads 3238
Green Belt 10685
ETP 277
Open Area 738
Others 4847
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
3
3.2 Project site selection
The main reason for selecting this site is industrial area has obtained Environmental
Clearance from MoEF &CC and consent to establish from Karnataka State Pollution
Control Board. Environmental Clearance is obtained for entire area by KIADB.
There are no endangered, threatened or rare plant species at the plant site or within the
10 kms radius of the industrial estate that need to be conserved. No noticeable impacts
on terrestrial life are anticipated. Industrial area is not a migration route to fauna.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
4
Topographical map of the Area
Toposheet Nos:
E43X2 E43X6
E43X3 E43X7
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
5
General Location
KIADB Industrial area
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
6
Site Layout
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
7
3.3.1 List of proposed Products
The proposed industry intends to produce the products given below. The proposed
installation capacity is 180 TPM
Bulk Drugs
Intermediates
Sl No Name of the product Proposed production in TPM
1 Dabigatran 4.50 2 Trityl-Olmesartan 4.50
Sl No Name of the product Proposed production in TPM
1. Atorvastatin Calcium 1.00 2. Ciprofloxacin.HCl.H2O 10.0
3. Clopidogrel bisulphate 2.00
4. Domperidone 3.00 5. Drotaverine 4.00
6. Esomeprazole Mg Trihydarete 1.00 7. Fexofinadine HCl 3.00 8. Fluconzole 2.00
9. Lamotrizine 1.60 10. Lansoprazole 2.00 11. Levo Citirizine HCl 3.00
12. Mebeverine 3.00 13. Montelukast sodium 0.50 14. Olmesartan 0.50
15. Omeprazole 3.00 16. Oxalamine Phosphate 1.50 17. Pantoprazole Sodium 3.00
18. Rabiprazole Sodium 0.50 19. Ractopomine 1.00 20. Sildnafil citrate 5.00
21. Telmisatran 4.50 22. Triclabendazole 10.00 23. Valsartan 3.00
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
8
Chemicals
Sl No
Name of the Intermediate Proposed production in TPD
1. Indole Derivatives 25.00 2. N-Butyl Lithium 8.40 3. Lithium Carbonate 10.00
4. Lithium Chloride 10.00 5. Sodium HMDS 5.00 6. Lithium HMDS 5.00
7. Lithium Tert Butoxide 0.50 8. N-Butyl Mg Chloride 20.0 9. Iso propyl Mg Chloride 8.40
10. Methyl Magnesium Chloride 1.00 11. Ethyl Magnesium Bromide 1.00 12. Tert Butyl Mg Chloride 1.00
13. Phenyl Mg Bromide 1.00 14. Phenyl Mg Chloride 2.00 15. Mg Tert Butoxide 0.50
Solvent Distillation
Sl No Name of the Intermediate Proposed production in TPD
1. All Solvents 25.00
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
9
Chemicals
Sl No Name of the Intermediate Proposed production in TPD
16. Indole Derivatives 25.00
17. N-Butyl Lithium 8.40 18. Lithium Carbonate 10.00 19. Lithium Chloride 10.00
20. Sodium HMDS 5.00 21. Lithium HMDS 5.00 22. Lithium Tert Butoxide 0.50
23. N-Butyl Mg Chloride 20.0
24. Iso propyl Mg Chloride 8.40 25. Methyl Magnesium Chloride 1.00
26. Ethyl Magnesium Bromide 1.00 27. Tert Butyl Mg Chloride 1.00 28. Phenyl Mg Bromide 1.00
29. Phenyl Mg Chloride 2.00 30. Mg Tert Butoxide 0.50
Solvent Distillation
Sl No Name of the Intermediate Proposed production in TPD
2. All Solvents 25.00
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
10
By-Products
Sl.No Name of the By-Product Quantity in TPM
1. 1-Bromo-5,5-dimethyl imidazolidine-2,4-dione 1.80
2. 2-Methylpentane 0.60 3. Acetaldehyde 0.39
4. Acetic acid 2.24 5. Ammonium Acetate 3.80 6. Copper Iodide 1.20 7. Dilute Bromo acetate 1.49
8. Dimethyl Sulfoxonium 0.50 9. Ethyl Benzene 1.20 10. Ethyl di isopropyl amine chloride 1.07
11. Ethyl Magnesium Bromide 0.12 12. Hydrobromic acid 0.63 13. Hydrogen Iodide 0.10
14. Hydroxy.Mg.Bromide 0.20 15. Iron(II) hydrate 0.64
16. Liq. Ammonia 1.57 17. Lithium Chloride 0.74 18. Methanesulfonic acid 0.08
19. Phosporic Acid 0.95 20. Piperazine HCl 2.90 21. Pot. Chloride 0.65
22. Pot. Acetate 0.86 23. Pot. Bromide solution 1.00 24. Pot. Iodide 1.09
25. Pot. Sulphate 2.95 26. Pot.Chloride 0.47 27. p-toluene sulfonic acid 0.10
28. Sod.Ethanoate 0.10 29. Sodium acetate 159
30. Sodium Bromide 0.73 31. Sodium Phosphate 1.30
32. Sodium Sulphate 1.06 33. Sodiumbicarbonate 0.1 34. Tributyl-methyl stanne 2.10
35. Triethylamine HCl 1.90 36. Triphenyl propionic acid 0.26
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
11
3.4 Brief Manufacturing process
Active raw materials of the respective products are charged into reactor using a solvent
as per the process batch sheet. After maintenance solvent is recovered by distillation for
next batch. Thus final product is isolated and purified with water wash and sometimes
with crystallsation with a suitable solvent.
3.5 Typical flow chart
Active inputSolventCatalyst
Reactor Solvent recovery
CentrifugeWater Waste water
Product
3.6 Raw materials requirement
Bulk drugs, Intermediates & Chemicals manufacturing involves the use of chemicals
and organic solvents either directly as reactant or for extraction of a product of interest
from the reaction mixture.
These materials required for the process is mostly bought from the local (indigenous)
market. Coal is used in the proposed boiler of 3 MT/hour. The coal consumption is
about 6.0 Tons per day. Diesel used for DG set of capacity 250KVA will be about 40
liters/hr at full operation load.
3.7 Resource Re-Cycling Optimizing /Re-cycling
All efforts will be made by the industry to carry out R& D on the isolated by-products /
wastes to minimize wherever possible. However R& D is a continuous process, where
improvement in the process adopted by the industry, waste minimization etc can be
worked out as the project progresses.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
12
3.8 Utilities
Sl.No Name of the utility Units 1 Coal Fired Boiler -3 TPH 1 2 Thermic Fluid Heater 2 KCal 1
3 GG Set -225KVA 1 4 Cooling Towers-400TR 2 5 Air Compressor-5 CFM/1 Kg
pressure 1
3.9 Water requirement
The total water requirement of the plant is 82M3/day. The water needs for the industry
will be met from KIADB supply.
3.10 Power requirement
The total power requirement of the plant is 350HP and is met from public supply. DG
set of 250KVA will be used only as stand by.
3.11 Wastewater generation & Proposed Treatment method
The wastewater generated from the production block will be subjected to primary
treatment and treated effluent will be pumped in to the R.C.C. tanks constructed above
ground level and will be lined with Acid proof tiles for storage and it will be sent to
Multiple Effect Evaporators for re-cycling till CETP is established. Condensate will be
reused appropriately. Salts from the MEE evaporation system will be collected and sent
to TSDF. Domestic waste water will be sent to septic tank.
3.12 Hazardous waste generation & Proposed Treatment method
Hazardous wastes generated from the plant are divided into Inorganic waste and
Organic waste. Inorganic wastes will be sent to TSDF for secured land fill. Organic
wastes will be sent to nearby cement plants for incineration along with spent Carbon.
Coal ash from boiler will be sold to suitable buyers.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
13
4. Site Analysis
Industrial area is well connected by Road and rail. It is beside to KA SH 15 connecting
between Yadgir and Bengaluru. Project area is a notified industrial area. Industrial area
has obtained Environmental Clearance from MoEF & CC in 2016
The area is well away from sensitive sites such as National parks, Wild life sanctuaries,
biosphere reserves, defense installations and religious places.
Temperatures in summer during day time is 400C and 250C during night times. During
monsoon it will be between 290C and 200C and in winter it will varies between 290C
during day time and 160C in the night. Relative humidity is between 60% and 65% .The
rainfall generally is spread over 49 days. Nearly 69% annual rainfall is between June
and September. A few showers will be received during the October. Maximum average
rainfall is 700mm in the area during monsoon period.
Secondary source
5. Brief Planning
Industry proposes to operate round the clock in shifts. Transportation of workers is a not
a concern as proposed industry provides transportation. Industry will engage private
operators for the purpose.
5.1. Rehabilitation and Resettlement
Since the industry is proposed on a notified industrial area, R& R is not required. By
providing direct and indirect employment to the locals and also by facilitating the
villages by conducting various developmental programs in a phased manner in
association with local bodies, Yadgir district will develop socio-economically.
5.2 Post project monitoring
The industry has definite environmental monitoring program to monitor the Ambient
Air Quality as well as Stack Emissions. The industry will install online monitoring
system as per the CPCB guidelines. Qualified staff appointed for the purpose will take
care of Operation and maintenance of the pollution control facilities. Stand-by facilities
will be provided to all the pumps so as to ensure fail proof treatment.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
14
5.3 Greenbelt development
5.3.1 Objective
The purpose of a green belt around the plant site is to capture the fugitive emission,
attenuate the noise generated and improve the aesthetics.
The green belt at the project site will form an effective barrier between the plant and the
surroundings. Open spaces, where tree plantation may not be possible, will be covered
with shrubs and grass to prevent erosion of topsoil. Adequate attention will be paid to
plantation of trees, their maintenance and protection. Green belt is being developed
around the periphery of the plant. Open spaces within the factory will be converted to
green areas in the form of lawns or flowering plants.
5.3.2 Plant species for green belt.
A wide range of plant species will be planted in and around the premises to help capture
the fugitive emission and noise levels form the plant premises. This wide range covers
plants of
Fast growing type.
With thick canopy cover
Perennial green nature
Native origin
A specialist in horticulture may be appointed to identify any other native species and
also supervise greenbelt development.
5.3.3 Design of Green Belt
As far possible the following guidelines will be considered in proposed green belt
development. Shrub and trees will be planted in encircling rows around the outer three
rows (away from planted side)
The short trees (<10 m height) will be planted in the first two rows (towards plant side)
of the green belt. The tall trees (>10 m height) will be planted in the outer three rows
(away from plant side).
Planting of trees in each row will be in staggered orientation.
In the front row, shrubs consisting of Callistemon, Prosodies etc. Will be grown.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
15
Since the trunks of the tall trees are generally devoid of foliage, it will be useful
to have shrubs in the fronts of the trees so as give coverage to this portion.
The spacing between the trees will be maintained slightly less than the normal spaces,
so that the trees may grow vertically and slightly increase the effective height of the
green belt.
5.4. Recycle of wastes
All efforts will be made by the industry to carryout R&D on the isolated by-products /
wastes to recycle / reuse wherever possible. However, R&D is a continuous process,
where improvement in the processes adopted by the industry, waste minimization etc
can be worked out as the project progresses.
6 Environment management cell
The unit will provide upgraded Environment Management cell as below:
6.1 Environment Management Cell
The Environment Management Cell shall include:
1. Manager 2. Process in charge from production 3. In charge Maintenance Department 4. In charge Operation ETP, Air Pollution Control Division, Solid waste
management with Chemist
7. Handling of raw materials and finished materials
The industry proposes to store the raw materials sufficient for one month of operations.
These raw materials and finished goods will be stored in the ware house as per safety
norms.
8. Hazardous Chemical, waste and Risk Assessment
Bulk Drugs, intermediate and Chemicals manufacturing industry has to handle many
such a chemicals that are hazardous in nature. The industry will provide special training
to the workers handling Hazardous chemical / wastes. The industry will engage safety
consultants to prepare a risk assessment and suggest safe handling and safe storage of
Hazardous wastes for the proposed project. Only highly trained personal with personal
projective Equipments (PPE’s) will be allowed to handle such chemicals or under strict
supervision.
Pre-Feasibility Report of M/s Sunlight Active Drug Ingredients Pvt.Ltd
16
9. Project schedule and cost estimates
Industry proposes to commence the production activity as soon as Environmental
Clearance and Consent to operate are granted by respective authorities.
The Total Gross proposed investment on Land, Buildings and Plant & Machinery is
about ₹.18.80 crore and the Unit has been registered under Small Scale Industry.
Industry has allocated an amount of about ₹.18.00 Lacs for Environmental Protection
measures including for green belt development.
∞